NeurogesX is a privately held specialty pharmaceutical company focusing on the development of products for the treatment of nerve signaling disorders. The company's initial products are focused on the treatment of chronic and acute pain. The company will also apply its basic science and clinical expertise in neurobiology to develop treatments for non-pain indications caused by aberrant nerve signaling.
